NCT06789315View on ClinicalTrials.gov

Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Alcoholic Hepatitis
Interventions
DRUG

Mycophenolate Mofetil

MMF at a dose of 750 mg twice daily for a period of 28 days,

DRUG

Prednisone

Prednisone at a dose of 40 mg for 28 days.

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT06789315 - Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter